ArticleJournal of robotic surgery2026
Disproportionate expansion of radical prostatectomy among older men in Japan in the robotic surgery era: a nationwide descriptive time series analysis.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robot-assisted radical prostatectomy (RARP) has rapidly expanded and become the leading surgical approach for prostate cancer in Japan. However, it remains unclear whether the concurrent increase in radical prostatectomy reflects population aging, increased diagnostic activity, or shifts in treatment selection after diagnosis. We performed a nationwide descriptive time-series analysis using publicly available Japanese administrative claims, cancer registry data, population statistics, and hospital function reports. We identified prostate cancer surgeries, laboratory testing, and prostate biopsies through reimbursement codes and analyzed them as annual claim counts. Surgical procedures were categorized as open, laparoscopic, minimally invasive endoscopic, or RARP. Trends from 2016 to 2024 were evaluated, and age-specific metrics for men aged 75-79, 80-84, and ≥ 85 years were referenced to 2018. Prostate cancer surgeries rose from 21,988 in 2016 to 29,548 in 2024. RARP procedures increased from 13,415 to 27,911, comprising 94.5% of all surgeries in 2024. The share of surgeries in men aged ≥ 75 years grew from 12.3% to 30.5% and among men aged ≥ 80 years, it rose from 0.9% to 4.7%. For men aged 80-84 years, the 2024 surgery index reached 463.0, surpassing the indices for population size, incidence, mortality, prostate-specific antigen testing, and biopsy. Radical prostatectomy increased disproportionately among older men in Japan, particularly those aged 80-84 years, predominantly through the expansion of RARP. These population-level trends highlight the need for individualized patient selection based on frailty, life expectancy, tumor risk, and expected treatment benefit to mitigate potential overtreatment in older men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.